ArticleTherapeutics and clinical risk management2021

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.

Toussaint Rouamba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.